Rapid identification of antisense mRNA-expressing clones using strand-specific RT-PCR

Antisense and Nucleic Acid Drug Development

Volumn 13, Issue 2, 2003, Pages 115-117

  Cummings, Michele ^a   McGurk, Claire ^a   Masters, John R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; MESSENGER RNA;

ARTICLE; CLONE; DNA TRANSFECTION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC SCREENING; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; WESTERN BLOTTING; CONTROLLED STUDY; GENE REPRESSION; MOLECULAR CLONING;

EID: 24344488463     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729003321629656     Document Type: Article

References (4)

1. LAYHER, S.K., and CLEAVER, J.E., (1996). Quantification of XPA gene expression levels in human and mouse cell lines by competitive RT-PCR. Mutat. Res. 383, 9-19.
2. MONEA, S., LEHTI, K., KESKI-OJA, J., and MIGNATTI, P. (2002). Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism. J. Cell. Physiol. 192, 160-170.
3. MOTWANI, M., SIROTNAK, F.M., SHE, Y., COMMES, T., and SCHWARTZ, G.K. (2002). Drg1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells. Cancer. Res. 62, 3950-3955.
4. YANG L.Y., LI, L., JIANG, H., SHEN, Y., and PLUNKETT, W. (2002). Expression of ERCC1 antisense RNA abrogates gemicitabine-mediated cytotoxic synergism with human colon tumor cells defective in mismatch repair. Clin. Cancer Res. 6, 773-781.